data_3MI
#
_chem_comp.id                                        3MI
_chem_comp.name                                      "2-(3,5-dichlorophenyl)-1,3-benzoxazole-6-carboxylic acid"
_chem_comp.type                                      NON-POLYMER
_chem_comp.pdbx_type                                 HETAIN
_chem_comp.formula                                   "C14 H7 Cl2 N O3"
_chem_comp.mon_nstd_parent_comp_id                   ?
_chem_comp.pdbx_synonyms                             Tafamidis
_chem_comp.pdbx_formal_charge                        0
_chem_comp.pdbx_initial_date                         2010-04-20
_chem_comp.pdbx_modified_date                        2012-05-25
_chem_comp.pdbx_ambiguous_flag                       N
_chem_comp.pdbx_release_status                       REL
_chem_comp.pdbx_replaced_by                          ?
_chem_comp.pdbx_replaces                             ?
_chem_comp.formula_weight                            308.116
_chem_comp.one_letter_code                           ?
_chem_comp.three_letter_code                         3MI
_chem_comp.pdbx_model_coordinates_details            ?
_chem_comp.pdbx_model_coordinates_missing_flag       N
_chem_comp.pdbx_ideal_coordinates_details            Corina
_chem_comp.pdbx_ideal_coordinates_missing_flag       N
_chem_comp.pdbx_model_coordinates_db_code            3MAI
_chem_comp.pdbx_subcomponent_list                    ?
_chem_comp.pdbx_processing_site                      RCSB

#
loop_
_chem_comp_atom.comp_id                        
_chem_comp_atom.atom_id                        
_chem_comp_atom.alt_atom_id                    
_chem_comp_atom.type_symbol                    
_chem_comp_atom.charge                         
_chem_comp_atom.pdbx_align                     
_chem_comp_atom.pdbx_aromatic_flag             
_chem_comp_atom.pdbx_leaving_atom_flag         
_chem_comp_atom.pdbx_stereo_config             
_chem_comp_atom.model_Cartn_x                  
_chem_comp_atom.model_Cartn_y                  
_chem_comp_atom.model_Cartn_z                  
_chem_comp_atom.pdbx_model_Cartn_x_ideal       
_chem_comp_atom.pdbx_model_Cartn_y_ideal       
_chem_comp_atom.pdbx_model_Cartn_z_ideal       
_chem_comp_atom.pdbx_component_atom_id         
_chem_comp_atom.pdbx_component_comp_id         
_chem_comp_atom.pdbx_ordinal                   
3MI  OAA  OAA  O 0 1 N N N  0.610 -1.036   0.433 -6.856 -0.249 -0.003  OAA 3MI  1
3MI  OAB  OAB  O 0 1 N N N  2.253 -2.074  -0.634 -5.924  1.766 -0.008  OAB 3MI  2
3MI  CAE  CAE  C 0 1 Y N N -0.063  0.402  -1.821 -4.255 -1.410  0.005  CAE 3MI  3
3MI  CAF  CAF  C 0 1 Y N N -0.538  1.035  -2.958 -3.006 -1.955  0.004  CAF 3MI  4
3MI  CAG  CAG  C 0 1 Y N N -0.070 -0.025 -10.408  4.314  0.214 -0.001  CAG 3MI  5
3MI  CAH  CAH  C 0 1 Y N N -0.397  1.170  -8.364  2.378 -1.198 -0.000  CAH 3MI  6
3MI  CAI  CAI  C 0 1 Y N N  0.305 -1.173  -8.351  2.132  1.204  0.002  CAI 3MI  7
3MI  CAJ  CAJ  C 0 1 Y N N  1.098 -1.275  -3.155 -3.307  0.822  0.000  CAJ 3MI  8
3MI  NAK  NAK  N 0 1 Y N N -0.538  0.883  -5.433 -0.550 -1.363  0.002  NAK 3MI  9
3MI  OAL  OAL  O 0 1 Y N N  0.690 -0.951  -5.604 -0.793  0.799  0.004  OAL 3MI 10
3MI  CAM  CAM  C 0 1 N N N  1.251 -1.333  -0.604 -5.778  0.560 -0.004  CAM 3MI 11
3MI  CAN  CAN  C 0 1 Y N N -0.415  1.130  -9.730  3.751 -1.051 -0.002  CAN 3MI 12
3MI  CAO  CAO  C 0 1 Y N N  0.288 -1.165  -9.717  3.506  1.338  0.000  CAO 3MI 13
3MI  CAP  CAP  C 0 1 Y N N  0.764 -0.708  -1.913 -4.422 -0.018  0.001  CAP 3MI 14
3MI  CAQ  CAQ  C 0 1 Y N N -0.046  0.003  -7.695  1.558 -0.069  0.001  CAQ 3MI 15
3MI  CAR  CAR  C 0 1 Y N N -0.003  0.011  -6.293  0.088 -0.219  0.002  CAR 3MI 16
3MI  CAS  CAS  C 0 1 Y N N -0.227  0.489  -4.190 -1.879 -1.124  0.003  CAS 3MI 17
3MI  CAT  CAT  C 0 1 Y N N  0.581 -0.643  -4.279 -2.038  0.273  0.004  CAT 3MI 18
3MI  CLC  CLC CL 0 0 N N N -0.825  2.539 -10.617  4.773 -2.454 -0.004  CLC 3MI 19
3MI  CLD  CLD CL 0 0 N N N  0.692 -2.593 -10.576  4.222  2.920  0.001  CLD 3MI 20
3MI HOAA HOAA  H 0 0 N N N  1.007 -1.462   1.184 -7.724  0.176 -0.006 HOAA 3MI 21
3MI  HAE  HAE  H 0 1 N N N -0.341  0.779  -0.848 -5.121 -2.054  0.006  HAE 3MI 22
3MI  HAF  HAF  H 0 1 N N N -1.136  1.932  -2.884 -2.886 -3.028  0.004  HAF 3MI 23
3MI  HAG  HAG  H 0 1 N N N -0.081 -0.035 -11.488  5.389  0.324  0.002  HAG 3MI 24
3MI  HAH  HAH  H 0 1 N N N -0.646  2.073  -7.826  1.939 -2.185 -0.000  HAH 3MI 25
3MI  HAI  HAI  H 0 1 N N N  0.581 -2.060  -7.800  1.502  2.081  0.003  HAI 3MI 26
3MI  HAJ  HAJ  H 0 1 N N N  1.722 -2.153  -3.231 -3.435  1.894 -0.003  HAJ 3MI 27
#
loop_
_chem_comp_bond.comp_id                  
_chem_comp_bond.atom_id_1                
_chem_comp_bond.atom_id_2                
_chem_comp_bond.value_order              
_chem_comp_bond.pdbx_aromatic_flag       
_chem_comp_bond.pdbx_stereo_config       
_chem_comp_bond.pdbx_ordinal             
3MI CAM  OAA SING N N  1
3MI OAA HOAA SING N N  2
3MI OAB  CAM DOUB N N  3
3MI CAF  CAE DOUB Y N  4
3MI CAP  CAE SING Y N  5
3MI CAE  HAE SING N N  6
3MI CAS  CAF SING Y N  7
3MI CAF  HAF SING N N  8
3MI CAG  CAN DOUB Y N  9
3MI CAG  CAO SING Y N 10
3MI CAG  HAG SING N N 11
3MI CAN  CAH SING Y N 12
3MI CAH  CAQ DOUB Y N 13
3MI CAH  HAH SING N N 14
3MI CAO  CAI DOUB Y N 15
3MI CAI  CAQ SING Y N 16
3MI CAI  HAI SING N N 17
3MI CAT  CAJ SING Y N 18
3MI CAJ  CAP DOUB Y N 19
3MI CAJ  HAJ SING N N 20
3MI CAR  NAK DOUB Y N 21
3MI NAK  CAS SING Y N 22
3MI CAR  OAL SING Y N 23
3MI OAL  CAT SING Y N 24
3MI CAP  CAM SING N N 25
3MI CLC  CAN SING N N 26
3MI CLD  CAO SING N N 27
3MI CAQ  CAR SING Y N 28
3MI CAT  CAS DOUB Y N 29
#
loop_
_pdbx_chem_comp_descriptor.comp_id               
_pdbx_chem_comp_descriptor.type                  
_pdbx_chem_comp_descriptor.program               
_pdbx_chem_comp_descriptor.program_version       
_pdbx_chem_comp_descriptor.descriptor            
3MI           SMILES              ACDLabs 12.01                                                            O=C(O)c1ccc2nc(oc2c1)c3cc(Cl)cc(Cl)c3
3MI SMILES_CANONICAL               CACTVS 3.370                                                            OC(=O)c1ccc2nc(oc2c1)c3cc(Cl)cc(Cl)c3
3MI           SMILES               CACTVS 3.370                                                            OC(=O)c1ccc2nc(oc2c1)c3cc(Cl)cc(Cl)c3
3MI SMILES_CANONICAL "OpenEye OEToolkits" 1.7.0                                                          c1cc2c(cc1C(=O)O)oc(n2)c3cc(cc(c3)Cl)Cl
3MI           SMILES "OpenEye OEToolkits" 1.7.0                                                          c1cc2c(cc1C(=O)O)oc(n2)c3cc(cc(c3)Cl)Cl
3MI            InChI                InChI  1.03 InChI=1S/C14H7Cl2NO3/c15-9-3-8(4-10(16)6-9)13-17-11-2-1-7(14(18)19)5-12(11)20-13/h1-6H,(H,18,19)
3MI         InChIKey                InChI  1.03                                                                      TXEIIPDJKFWEEC-UHFFFAOYSA-N
#
loop_
_pdbx_chem_comp_identifier.comp_id               
_pdbx_chem_comp_identifier.type                  
_pdbx_chem_comp_identifier.program               
_pdbx_chem_comp_identifier.program_version       
_pdbx_chem_comp_identifier.identifier            
3MI "SYSTEMATIC NAME"              ACDLabs 12.01 "2-(3,5-dichlorophenyl)-1,3-benzoxazole-6-carboxylic acid"
3MI "SYSTEMATIC NAME" "OpenEye OEToolkits" 1.7.0 "2-(3,5-dichlorophenyl)-1,3-benzoxazole-6-carboxylic acid"
#
loop_
_pdbx_chem_comp_audit.comp_id               
_pdbx_chem_comp_audit.action_type           
_pdbx_chem_comp_audit.date                  
_pdbx_chem_comp_audit.processing_site       
_pdbx_chem_comp_audit.annotator             
_pdbx_chem_comp_audit.details               
3MI     "Create component" 2010-04-20 RCSB  ? ?
3MI "Modify aromatic_flag" 2011-06-04 RCSB  ? ?
3MI    "Modify descriptor" 2011-06-04 RCSB  ? ?
3MI    "Modify descriptor" 2012-05-22 RCSB LD ?
#
_pdbe_chem_comp_drugbank_details.comp_id                   3MI
_pdbe_chem_comp_drugbank_details.drugbank_id               DB11644
_pdbe_chem_comp_drugbank_details.type                      "small molecule"
_pdbe_chem_comp_drugbank_details.name                      Tafamidis
_pdbe_chem_comp_drugbank_details.description               "Tafamidis is a novel specific transthyretin (TTR) stabilizer or dissociation inhibitor. TTR ordinarily assumes a tetramer configuration that primarily serves to transport retinol-binding protein-vitamin A complex as well as thyroxine (to a small degree) in the blood. In TTR-related disorders such as TTR familial amyloid polyneuropathy (TTR-FAP), tetramer dissociation is accelerated and results in unregulated amyloidogenesis and amyloid fibril formation. The unwanted deposition of such formations in various tissues eventually contributes to the failure of autonomic and peripheral nervous system functions.  Tafamidis was approved by the European Medicines Agency (EMA) in 2011 under the market name Vyndaqel for the treatment of transthyretin familial amyloid polyneuropathy (TTR-FAP) in adult patients with early-stage symptomatic polyneuropathy to delay peripheral neurologic impairment. In June 2017, Pfizer received FDA Fast Track Designation for tafamidis which was later approved in May, 2019 for use in the treatment of cardiomyopathy in wild type or hereditary transthyretin-mediated amyloidosis.  Tafamidis was developed by Jeffery W. Kelly in the company FoldRx that he had co-founded with Susan Lindquist of MIT and the Whitehead Institute."
_pdbe_chem_comp_drugbank_details.cas_number                594839-88-0
_pdbe_chem_comp_drugbank_details.mechanism_of_action       "Transthyretin (TTR) amyloid polyneuropathy (also known as TTR familial amyloid polyneuropathy, TTR-FAP) results from genetic mutations in the TTR gene that cause destabilization of ordinary TTR tetramers and/or speed up TTR tetramer dissociation into monomers [A27206]. TTR-FAP itself is a multi-faceted, progressive, axonal degenerative neuropathy characterized by sensory, motor, and autonomic impairment [FDA Label].  The dissociation of TTR tetramers to monomers is, in fact, the rate-limiting step in the pathogenesis of TTR-FAP [FDA Label]. The folded monomers that comprise ordinary TTR tetramers undergo partial denaturation to produce alternatively folded monomeric amyloidogenic intermediates [FDA Label]. These intermediates then misassemble into a variety of soluble oligomers, profilaments, filaments, and amyloid fibrils [FDA Label]. These various undesired, soluble aggregates subsequently deposit upon tissues where they ultimately are not expected to be present or needed [A27206]. In particular, studies demonstrating TTR's ability to influence nerve physiology by enhancing nerve regeneration in mouse models [A32598] emphasizes a potential function of TTR for nerve biology and repair that may assist in explaining why mutant TTR aggregrates preferentially deposit in the peripheral nervous system of patients with TTR-FAP [A27206].  Tafamidis is subsequently a rationally designed pharmaceutical that specifically binds non-cooperatively to the two thyroxine binding sites on the native tetrameric form of TTR to prevent its dissociation into monomers [FDA Label]. Tafamidis is consequently formally considered to be a specific stabilizer of TTR, and its inhibition of TTR tetramer dissociation forms the rationale for its use as a treatment to slow - but not cure - the disease progression of TTR-FAP [FDA Label]."

#
_pdbe_chem_comp_drugbank_classification.comp_id           3MI
_pdbe_chem_comp_drugbank_classification.drugbank_id       DB11644
_pdbe_chem_comp_drugbank_classification.parent            Phenyl-1,3-oxazoles
_pdbe_chem_comp_drugbank_classification.kingdom           "Organic compounds"
_pdbe_chem_comp_drugbank_classification.class             Azoles
_pdbe_chem_comp_drugbank_classification.superclass        "Organoheterocyclic compounds"
_pdbe_chem_comp_drugbank_classification.description       "This compound belongs to the class of organic compounds known as phenyl-1,3-oxazoles. These are aromatic heterocyclic compounds containing a 1,3-oxazole substituted at one or more positions by a phenyl group."

#
_pdbe_chem_comp_drugbank_targets.comp_id                        3MI
_pdbe_chem_comp_drugbank_targets.drugbank_id                    DB11644
_pdbe_chem_comp_drugbank_targets.name                           Transthyretin
_pdbe_chem_comp_drugbank_targets.organism                       Humans
_pdbe_chem_comp_drugbank_targets.uniprot_id                     P02766
_pdbe_chem_comp_drugbank_targets.pharmacologically_active       yes
_pdbe_chem_comp_drugbank_targets.ordinal                        1

#
loop_
_pdbx_chem_comp_synonyms.comp_id          
_pdbx_chem_comp_synonyms.name             
_pdbx_chem_comp_synonyms.provenance       
3MI Tafamidis   ChEMBL
3MI  Vyndaqel   ChEMBL
3MI   FX-1006   ChEMBL
3MI Tafamidis DrugBank
#
loop_
_software.name              
_software.version           
_software.description       
       rdkit 2019.03.2                                      "Core functionality."
pdbeccdutils     0.5.2 "Wrapper to provide 2D templates and molecular fragments."
#
loop_
_pdbe_chem_comp_atom_depiction.comp_id             
_pdbe_chem_comp_atom_depiction.atom_id             
_pdbe_chem_comp_atom_depiction.element             
_pdbe_chem_comp_atom_depiction.model_Cartn_x       
_pdbe_chem_comp_atom_depiction.model_Cartn_y       
_pdbe_chem_comp_atom_depiction.pdbx_ordinal        
3MI OAA  O  3.805  0.549  1
3MI OAB  O  5.104  2.799  2
3MI CAE  C  6.404 -0.951  3
3MI CAF  C  7.702 -1.701  4
3MI CAG  C 15.796 -0.201  5
3MI CAH  C 13.546  1.098  6
3MI CAI  C 13.546 -1.500  7
3MI CAJ  C  7.702  1.299  8
3MI NAK  N 10.421 -1.408  9
3MI OAL  O 10.421  1.006 10
3MI CAM  C  5.104  1.299 11
3MI CAN  C 15.046  1.098 12
3MI CAO  C 15.046 -1.500 13
3MI CAP  C  6.404  0.549 14
3MI CAQ  C 12.796 -0.201 15
3MI CAR  C 11.296 -0.201 16
3MI CAS  C  9.002 -0.951 17
3MI CAT  C  9.002  0.549 18
3MI CLC Cl 15.796  2.397 19
3MI CLD Cl 15.796 -2.799 20
#
loop_
_pdbe_chem_comp_bond_depiction.comp_id            
_pdbe_chem_comp_bond_depiction.atom_id_1          
_pdbe_chem_comp_bond_depiction.atom_id_2          
_pdbe_chem_comp_bond_depiction.value_order        
_pdbe_chem_comp_bond_depiction.bond_dir           
_pdbe_chem_comp_bond_depiction.pdbx_ordinal       
3MI CAM OAA SINGLE NONE  1
3MI OAB CAM DOUBLE NONE  2
3MI CAF CAE DOUBLE NONE  3
3MI CAP CAE SINGLE NONE  4
3MI CAS CAF SINGLE NONE  5
3MI CAG CAN DOUBLE NONE  6
3MI CAG CAO SINGLE NONE  7
3MI CAN CAH SINGLE NONE  8
3MI CAH CAQ DOUBLE NONE  9
3MI CAO CAI DOUBLE NONE 10
3MI CAI CAQ SINGLE NONE 11
3MI CAT CAJ SINGLE NONE 12
3MI CAJ CAP DOUBLE NONE 13
3MI CAR NAK DOUBLE NONE 14
3MI NAK CAS SINGLE NONE 15
3MI CAR OAL SINGLE NONE 16
3MI OAL CAT SINGLE NONE 17
3MI CAP CAM SINGLE NONE 18
3MI CLC CAN SINGLE NONE 19
3MI CLD CAO SINGLE NONE 20
3MI CAQ CAR SINGLE NONE 21
3MI CAT CAS DOUBLE NONE 22
#
loop_
_pdbe_chem_comp_substructure.comp_id                      
_pdbe_chem_comp_substructure.substructure_name            
_pdbe_chem_comp_substructure.id                           
_pdbe_chem_comp_substructure.substructure_type            
_pdbe_chem_comp_substructure.substructure_smiles          
_pdbe_chem_comp_substructure.substructure_inchis          
_pdbe_chem_comp_substructure.substructure_inchikeys       
3MI MurckoScaffold S1 scaffold c1ccc(-c2nc3ccccc3o2)cc1 InChI=1S/C13H9NO/c1-2-6-10(7-3-1)13-14-11-8-4-5-9-12(11)15-13/h1-9H FIISKTXZUZBTRC-UHFFFAOYSA-N
3MI    benzoxazole F1 fragment            c1ccc2ocnc2c1                        InChI=1S/C7H5NO/c1-2-4-7-6(3-1)8-5-9-7/h1-5H BCMCBBGGLRIHSE-UHFFFAOYSA-N
3MI        oxazole F2 fragment                  c1cocn1                                  InChI=1S/C3H3NO/c1-2-5-3-4-1/h1-3H ZCQWOFVYLHDMMC-UHFFFAOYSA-N
3MI         phenyl F3 fragment                 c1ccccc1                                  InChI=1S/C6H6/c1-2-4-6-5-3-1/h1-6H UHOVQNZJYSORNB-UHFFFAOYSA-N
#
loop_
_pdbe_chem_comp_substructure_mapping.comp_id                    
_pdbe_chem_comp_substructure_mapping.atom_id                    
_pdbe_chem_comp_substructure_mapping.substructure_id            
_pdbe_chem_comp_substructure_mapping.substructure_ordinal       
3MI CAT F1 1
3MI OAL F1 1
3MI CAR F1 1
3MI NAK F1 1
3MI CAS F1 1
3MI CAF F1 1
3MI CAE F1 1
3MI CAP F1 1
3MI CAJ F1 1
3MI CAT F2 1
3MI CAS F2 1
3MI NAK F2 1
3MI CAR F2 1
3MI OAL F2 1
3MI CAE F3 1
3MI CAF F3 1
3MI CAS F3 1
3MI CAT F3 1
3MI CAJ F3 1
3MI CAP F3 1
3MI CAG F3 2
3MI CAN F3 2
3MI CAH F3 2
3MI CAQ F3 2
3MI CAI F3 2
3MI CAO F3 2
3MI CAE S1 1
3MI CAF S1 1
3MI CAG S1 1
3MI CAH S1 1
3MI CAI S1 1
3MI CAJ S1 1
3MI NAK S1 1
3MI OAL S1 1
3MI CAN S1 1
3MI CAO S1 1
3MI CAP S1 1
3MI CAQ S1 1
3MI CAR S1 1
3MI CAS S1 1
3MI CAT S1 1
#
_pdbe_chem_comp_rdkit_properties.comp_id                               3MI
_pdbe_chem_comp_rdkit_properties.exactmw                               306.980
_pdbe_chem_comp_rdkit_properties.lipinskiHBA                           4
_pdbe_chem_comp_rdkit_properties.lipinskiHBD                           1
_pdbe_chem_comp_rdkit_properties.NumRotatableBonds                     2
_pdbe_chem_comp_rdkit_properties.NumHBD                                1
_pdbe_chem_comp_rdkit_properties.NumHBA                                4
_pdbe_chem_comp_rdkit_properties.NumHeteroatoms                        6
_pdbe_chem_comp_rdkit_properties.NumAmideBonds                         0
_pdbe_chem_comp_rdkit_properties.FractionCSP3                          0
_pdbe_chem_comp_rdkit_properties.NumRings                              3
_pdbe_chem_comp_rdkit_properties.NumAromaticRings                      3
_pdbe_chem_comp_rdkit_properties.NumAliphaticRings                     0
_pdbe_chem_comp_rdkit_properties.NumSaturatedRings                     0
_pdbe_chem_comp_rdkit_properties.NumHeterocycles                       1
_pdbe_chem_comp_rdkit_properties.NumAromaticHeterocycles               1
_pdbe_chem_comp_rdkit_properties.NumSaturatedHeterocycles              0
_pdbe_chem_comp_rdkit_properties.NumAliphaticHeterocycles              0
_pdbe_chem_comp_rdkit_properties.NumSpiroAtoms                         0
_pdbe_chem_comp_rdkit_properties.NumBridgeheadAtoms                    0
_pdbe_chem_comp_rdkit_properties.NumAtomStereoCenters                  0
_pdbe_chem_comp_rdkit_properties.NumUnspecifiedAtomStereoCenters       0
_pdbe_chem_comp_rdkit_properties.labuteASA                             133.033
_pdbe_chem_comp_rdkit_properties.tpsa                                  63.330
_pdbe_chem_comp_rdkit_properties.CrippenClogP                          3.637
_pdbe_chem_comp_rdkit_properties.CrippenMR                             72.630
_pdbe_chem_comp_rdkit_properties.NumHeavyAtoms                         20

#
loop_
_pdbe_chem_comp_external_mappings.comp_id           
_pdbe_chem_comp_external_mappings.source            
_pdbe_chem_comp_external_mappings.resource          
_pdbe_chem_comp_external_mappings.resource_id       
3MI UniChem    ChEMBL    CHEMBL2103837
3MI UniChem  DrugBank          DB11644
3MI UniChem     ChEBI            78538
3MI UniChem      ZINC ZINC000043206271
3MI UniChem BindingDb         50197883
#
loop_
_pdbe_chem_comp_rdkit_conformer.comp_id             
_pdbe_chem_comp_rdkit_conformer.atom_id             
_pdbe_chem_comp_rdkit_conformer.Cartn_x_rdkit       
_pdbe_chem_comp_rdkit_conformer.Cartn_y_rdkit       
_pdbe_chem_comp_rdkit_conformer.Cartn_z_rdkit       
_pdbe_chem_comp_rdkit_conformer.rdkit_method        
_pdbe_chem_comp_rdkit_conformer.rdkit_ordinal       
3MI  OAA  5.463  1.712 -0.474 ETKDGv2  1
3MI  OAB  6.038 -0.316  0.400 ETKDGv2  2
3MI  CAE  3.459 -1.531  0.022 ETKDGv2  3
3MI  CAF  2.201 -2.010  0.024 ETKDGv2  4
3MI  CAG -5.095  0.520 -0.117 ETKDGv2  5
3MI  CAH -2.795  1.342 -0.125 ETKDGv2  6
3MI  CAI -3.235 -1.061 -0.054 ETKDGv2  7
3MI  CAJ  2.673  0.806 -0.063 ETKDGv2  8
3MI  NAK -0.300 -1.316 -0.024 ETKDGv2  9
3MI  OAL  0.103  0.905 -0.089 ETKDGv2 10
3MI  CAM  5.120  0.439 -0.018 ETKDGv2 11
3MI  CAN -4.257  1.564 -0.143 ETKDGv2 12
3MI  CAO -4.559 -0.857 -0.070 ETKDGv2 13
3MI  CAP  3.721 -0.051 -0.031 ETKDGv2 14
3MI  CAQ -2.298  0.092 -0.082 ETKDGv2 15
3MI  CAR -0.838 -0.131 -0.065 ETKDGv2 16
3MI  CAS  1.095 -1.046 -0.022 ETKDGv2 17
3MI  CAT  1.314  0.245 -0.060 ETKDGv2 18
3MI  CLC -4.888  3.200 -0.198 ETKDGv2 19
3MI  CLD -5.664 -2.219 -0.037 ETKDGv2 20
3MI HOAA  4.798  2.332 -0.918 ETKDGv2 21
3MI  HAE  4.287 -2.228  0.052 ETKDGv2 22
3MI  HAF  2.010 -3.075  0.059 ETKDGv2 23
3MI  HAG -6.166  0.678 -0.130 ETKDGv2 24
3MI  HAH -2.136  2.201 -0.146 ETKDGv2 25
3MI  HAI -2.850 -2.073 -0.020 ETKDGv2 26
3MI  HAJ  2.799  1.879 -0.060 ETKDGv2 27
#
